These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 215062)

  • 21. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Field trial with a subunit rhinopneumovaccine].
    Theunissen GT; van Essen GJ; van Maanen C; Schrijver RS
    Tijdschr Diergeneeskd; 1995 Feb; 120(3):72-4. PubMed ID: 7846673
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccines for EHV1.
    Baker GJ
    Vet Rec; 1983 Jan; 112(5):110-1. PubMed ID: 6298987
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccines for equine herpesvirus type 1.
    Studdert MJ
    Vet Rec; 1983 Apr; 112(14):334. PubMed ID: 6304985
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of a live equine herpesvirus-1 (EHV-1) strain C147 vaccine in foals with maternally-derived antibody: protection against EHV-1 infection.
    Patel JR; Didlick S; Bateman H
    Equine Vet J; 2004 Jul; 36(5):447-51. PubMed ID: 15253088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines for EHV1 abortion.
    Mitchell D
    Vet Rec; 1983 Mar; 112(12):285. PubMed ID: 6302971
    [No Abstract]   [Full Text] [Related]  

  • 27. Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine.
    Studdert MJ
    Vaccine; 2002 Jan; 20(7-8):992. PubMed ID: 11803056
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.
    Gerber JD; Marron AE; Bass EP; Beckenhauer WH
    Can J Comp Med; 1977 Oct; 41(4):471-8. PubMed ID: 200320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of a thymidine kinase negative equine herpesvirus-1 vaccine in young horses.
    Cornick J; Martens J; Martens R; Crandell R; McConnell S; Kit S
    Can J Vet Res; 1990 Apr; 54(2):260-6. PubMed ID: 2162730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunity to equine herpesvirus 1 infection in foals during the first year of life.
    Kendrick JW; Stevenson W
    J Reprod Fertil Suppl; 1979; (27):615-8. PubMed ID: 225497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serologic responses of pregnant thoroughbred mares to vaccination with an inactivated equine herpesvirus 1 vaccine.
    Bryans JT
    Am J Vet Res; 1980 Nov; 41(11):1743-6. PubMed ID: 6259970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity to equine herpesvirus type 1 (rhinopneumonitis): in vitro lymphocyte response.
    Wilks CR; Coggins L
    Am J Vet Res; 1976 May; 37(5):486-92. PubMed ID: 179451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Training of the immune system of foals against ERP virus infections by frequent vaccination with presently available commercial vaccines].
    Bürki F; Nowotny N; Rossmanith W; Pallan C; Möstl K
    Dtsch Tierarztl Wochenschr; 1989 Apr; 96(4):162-5. PubMed ID: 2540944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Third International Havemeyer Workshop on Equine Herpesvirus type 1.
    Kydd JH; Slater J; Osterrieder N; Lunn DP; Antczak DF; Azab W; Balasuriya U; Barnett C; Brosnahan M; Cook C; Damiani A; Elton D; Frampton A; Gilkerson J; Goehring L; Horohov D; Maxwell L; Minke J; Morley P; Nauwynck H; Newton R; Perkins G; Pusterla N; Soboll-Hussey G; Traub-Dargatz J; Townsend H; Van de Walle GR; Wagner B
    Equine Vet J; 2012 Sep; 44(5):513-7. PubMed ID: 22888774
    [No Abstract]   [Full Text] [Related]  

  • 37. Measurement of neutralizing antibody to equid herpesvirus 1 by single radial hemolysis.
    Klingeborn B; Dinter Z
    J Clin Microbiol; 1978 May; 7(5):495-6. PubMed ID: 207720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Creation of an avirulent and immunogenic mutant from the rhinopneumonitis virus].
    Tatarov G; Dilovski M
    Vet Med Nauki; 1986; 23(7):33-40. PubMed ID: 3024389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
    Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
    Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review.
    Patel JR; Heldens J
    Vet J; 2005 Jul; 170(1):14-23. PubMed ID: 15993786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.